Literature DB >> 16781757

Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein.

Myriam Troesch1, Isabelle Meunier, Pascal Lapierre, Normand Lapointe, Fernando Alvarez, Marc Boucher, Hugo Soudeyns.   

Abstract

A large share of hepatitis C virus amino acid sequence variation is concentrated within two hypervariable regions located at the N-terminus of the E2 envelope glycoprotein (HVR1 and HVR2). Interhost and intrahost comparison of 391 E2 sequences derived from 17 subjects infected with HCV using amino acid entropy revealed clustering of amino acid variability at a third site (residues 431-466), which was termed HVR3. Genetic distance analysis supported the division of HVR3 into three subdomains (HVR3a, HVR3b, and HVR3c). Study of synonymous and nonsynonymous nucleic acid substitutions confirmed that HVR3a was subjected to strong intrahost-selective pressure. Physicochemical and antigenicity predictions, conservation of key residues, and molecular modeling were concordant with one another and further validated the proposed organization of HVR3. Taken together, these results are suggestive of a role for HVR3 in cell surface receptor binding and viral entry akin to that proposed for HVR1 and HVR2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781757     DOI: 10.1016/j.virol.2006.05.015

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.

Authors:  Kathleen McCaffrey; Irene Boo; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

2.  Synthetic antigens representing the antigenic variation of human hepatitis C virus.

Authors:  Kyung Hee Kang; Yasuhiro Yamamura; Maria P Carlos; Nicolas Karvelas; In-Sup Kim; Deepa Sunkara; Rebecca Rivera; Murray B Gardner; David E Anderson; Francisco Diaz-Mitoma; José Torres; Juan P Marquez
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

Review 3.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants.

Authors:  Nicholas Renzette; Bornali Bhattacharjee; Jeffrey D Jensen; Laura Gibson; Timothy F Kowalik
Journal:  PLoS Pathog       Date:  2011-05-19       Impact factor: 6.823

5.  Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.

Authors:  Nicholas Renzette; Mohan Somasundaran; Frank Brewster; James Coderre; Eric R Weiss; Margaret McManus; Thomas Greenough; Barbara Tabak; Manuel Garber; Timothy F Kowalik; Katherine Luzuriaga
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

6.  Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.

Authors:  Isla Humphreys; Vicki Fleming; Paolo Fabris; Joe Parker; Bodo Schulenberg; Anthony Brown; Charis Demetriou; Silvana Gaudieri; Katja Pfafferott; Michaela Lucas; Jane Collier; Kuan-Hsiang Gary Huang; Oliver G Pybus; Paul Klenerman; Eleanor Barnes
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

7.  Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.

Authors:  Vanessa M Cowton; Allan G N Angus; Sarah J Cole; Christina K Markopoulou; Ania Owsianka; James I Dunlop; Deborah E Gardner; Thomas Krey; Arvind H Patel
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

8.  Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein.

Authors:  Gabrielle Vieyres; Jean Dubuisson; Arvind H Patel
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

9.  Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks.

Authors:  John M Murray; Rémy Moenne-Loccoz; Aurélie Velay; François Habersetzer; Michel Doffoël; Jean-Pierre Gut; Isabel Fofana; Mirjam B Zeisel; Françoise Stoll-Keller; Thomas F Baumert; Evelyne Schvoerer
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

Review 10.  Pathogenesis of hepatitis C during pregnancy and childhood.

Authors:  Armelle Le Campion; Ariane Larouche; Sébastien Fauteux-Daniel; Hugo Soudeyns
Journal:  Viruses       Date:  2012-12-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.